title: First test of WTO mechanism for procuring generic medicines under compulsory licence, via Canada's Access to Medicines Regime.
abstract: In July 2007, Rwanda became the first nation to initiate use of a procedure under the rules of the World Trade Organization (WTO) that is supposed to let developing countries import lower-cost, generic medicines produced in other countries under compulsory licences. And two months later, based on Rwanda's initiative, Canada's Commissioner of Patents issued the first compulsory licence under this system to permit the production of a patented AIDS drug to that country.
authors.forename: Richard
authors.initials: R
authors.lastname: Elliott
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy*; D019380:Anti-HIV Agents / Q000191:economics / Q000627:therapeutic use; D002170:Canada; D003906:Developing Countries; D016568:Drugs, Generic / Q000191:economics / Q000627:therapeutic use*; D014943:Global Health; D006801:Humans; D008009:Licensure, Pharmacy / Q000331:legislation & jurisprudence; D012432:Rwanda
chemical_list: D019380:Anti-HIV Agents; D016568:Drugs, Generic